MedTrace Logo

In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids

NCT05604001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-07-24

No results posted yet for this study

Summary

To evaluate feasibility and efficacy of in-office hysteroscopic ablation of submucous uterine fibroid using diode laser

Conditions

  • Laser Hysteroscopic Ablation of Submucous Myoma

Interventions

DEVICE

hysteroscopic ablation of submucous uterine fibroid using diode laser

patients with symptomatic submucosal fibroids (heavy menstrual bleeding) were elected for hysteroscopy and laser ablation of the myoma

Sponsors & Collaborators

  • Ariel University

    lead OTHER

Principal Investigators

  • Sergio Haimovich, MD, PhD · Laniado University Hospital - Ariel University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-30
Completion
2019-12-30

Countries

  • Israel
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05604001 on ClinicalTrials.gov